Agilent Technologies (A) EBITDA Margin (2010 - 2026)
Agilent Technologies (A) posted quarterly EBITDA Margin of 21.74% for Q2 2026, up 376.0% year-over-year from 4.57% in Q2 2025, and up 10.75% sequentially from 19.63% in Q1 2026.
Agilent Technologies (A) EBITDA Margin (2010 - 2026) Analysis & Trends
Agilent Technologies has disclosed EBITDA Margin across 17 years of filings, most recently posting 21.74% for Q2 2026.
- For the quarter ending Q2 2026, EBITDA Margin rose 376.0% year-over-year to 21.74%; the trailing twelve-month figure through Apr 2026 stood at 21.5% (up 12.0% YoY), and the FY2025 full-year result was 21.29%, down 157.0% from the prior year.
- EBITDA Margin was 21.74% for Q2 2026 at Agilent Technologies, up from 19.63% in the prior quarter.
- Over five years, EBITDA Margin peaked at 25.47% in Q4 2022 and troughed at 7.95% in Q3 2023.
- The 5-year median for EBITDA Margin is 22.43% (2022), against an average of 21.7%.
- Year-over-year, EBITDA Margin slumped 1597 bps in 2023 and surged 1315 bps in 2024.
- Year by year, EBITDA Margin stood at 25.47% in 2022, then declined by 5 bps to 24.17% in 2023, then fell by 1 bps to 23.99% in 2024, then slipped by 1 bps to 23.8% in 2025, then fell by 9 bps to 21.74% in 2026.
- Per Business Quant, the three latest an EBITDA Margin figures stand at 21.74% (Q2 2026), 19.63% (Q1 2026), and 23.8% (Q4 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 31.78% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 21.74% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 12.38% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -12.21% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 19.42% |
| 10 | Quest Diagnostics | 21.68 Bn | 21.59 Bn | 942.00 Mn | 13.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 21.74% |
| Jan 31, 2026 | 19.63% |
| Oct 31, 2025 | 23.80% |
| Jul 31, 2025 | 20.71% |
| Apr 30, 2025 | 17.99% |
| Jan 31, 2025 | 22.37% |
| Oct 31, 2024 | 23.99% |
| Jul 31, 2024 | 21.10% |
| Apr 30, 2024 | 23.08% |
| Jan 31, 2024 | 23.16% |
| Oct 31, 2023 | 24.17% |
| Jul 31, 2023 | 7.95% |
| Apr 30, 2023 | 22.31% |
| Jan 31, 2023 | 24.26% |
| Oct 31, 2022 | 25.47% |
| Jul 31, 2022 | 23.92% |
| Apr 30, 2022 | 22.40% |
| Jan 31, 2022 | 22.46% |
| Oct 31, 2021 | 23.80% |
| Jul 31, 2021 | 21.19% |